课题基金 / 基金详情

New drugs for antibiotic resistant bacterial infections

New drugs for antibiotic resistant bacterial infections
治疗耐药细菌感染的新药
批准号:
213053
负责人:
Dmitrienko Gary I
金额:
$9.71万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2010
资助国家:
加拿大
项目状态:
已结题
起止时间:
2010-09-01 至 2011-09-01

项目摘要

项目成果

Dmitrienko Gary I的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Recent scientific discoveries at the University of Waterloo have led to the founding of a startup drug discovery company, Waterloo Pharmaceuticals Inc., in order to pursue practical solutions to serious health problems posed by bacterial infections th
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Carbapenemase inhibitors for use as adjuvants in treating carbapenem-resistant bacterial infections
  • 批准号:
    410078
  • 项目类别:
    Operating Grants
  • 资助金额:
    $49.04万
  • 财政年份:
    2019
  • 负责人:
    Dmitrienko Gary I
  • 依托单位:
New strategies for overcoming bacterial resistance to antibiotics
  • 批准号:
    252944
  • 项目类别:
    Operating Grants
  • 资助金额:
    $14.57万
  • 财政年份:
    2012
  • 负责人:
    Dmitrienko Gary I
  • 依托单位:
Canada-UK Team in Bacterial Resistance to Beta-Lactam Antibiotics
  • 批准号:
    223658
  • 项目类别:
    Operating Grants
  • 资助金额:
    $144.09万
  • 财政年份:
    2011
  • 负责人:
    Dmitrienko Gary I
  • 依托单位:
Broad spectrum beta lactamase inhibitors to counter antibiotic resistance
  • 批准号:
    201421
  • 项目类别:
    Operating Grants
  • 资助金额:
    $51.7万
  • 财政年份:
    2010
  • 负责人:
    Dmitrienko Gary I
  • 依托单位: